90 related articles for article (PubMed ID: 38611057)
1. Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population.
Kılınç MT; Göger YE; Özkent MS; Kılıç Ö; Okur Altındaş B; Yıldırım MS; Karalezli G
Urol J; 2024 Jun; 21(4):242-249. PubMed ID: 38629199
[TBL] [Abstract][Full Text] [Related]
2. Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer.
Regouc M; Belge G; Lorch A; Dieckmann KP; Pichler M
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32235691
[TBL] [Abstract][Full Text] [Related]
3. Advancing GCT Management: A Review of miR-371a-3p and Other miRNAs in Comparison to Traditional Serum Tumor Markers.
Seales CL; Puri D; Yodkhunnatham N; Pandit K; Yuen K; Murray S; Smitham J; Lafin JT; Bagrodia A
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611057
[TBL] [Abstract][Full Text] [Related]
4. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G
Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.
Murray MJ; Ajithkumar T; Harris F; Williams RM; Jalloh I; Cross J; Ronghe M; Ward D; Scarpini CG; Nicholson JC; Coleman N
Neurooncol Adv; 2020; 2(1):vdaa048. PubMed ID: 32642701
[TBL] [Abstract][Full Text] [Related]
6. The present and future of serum diagnostic tests for testicular germ cell tumours.
Murray MJ; Huddart RA; Coleman N
Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472
[TBL] [Abstract][Full Text] [Related]
7. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
Syring I; Bartels J; Holdenrieder S; Kristiansen G; Müller SC; Ellinger J
J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
[TBL] [Abstract][Full Text] [Related]
8. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
[TBL] [Abstract][Full Text] [Related]
9. Novel approaches to redesign surveillance strategies following orchiectomy for localized testicular cancer: a narrative review.
Matulewicz RS; Fankhauser CD; Sheinfeld J; Bagrodia A
Transl Androl Urol; 2023 Jun; 12(6):1016-1022. PubMed ID: 37426604
[TBL] [Abstract][Full Text] [Related]
10. Refining the serum miR-371a-3p test for viable germ cell tumor detection.
Lafin JT; Scarpini CG; Amini A; Konneh B; Howard JM; Gerald T; Nuno M; Piao J; Savelyeva A; Wang Z; Gagan J; Jia L; Lewis CM; Murray S; Sawa YC; Margulis V; Woldu SL; Strand DW; Coleman N; Amatruda JF; Frazier AL; Murray MJ; Bagrodia A
Sci Rep; 2023 Jun; 13(1):10558. PubMed ID: 37386046
[TBL] [Abstract][Full Text] [Related]
11. Treatment de-escalation for stage II seminoma.
Wood GE; Chamberlain F; Tran B; Conduit C; Liow E; Nicol DL; Shamash J; Alifrangis C; Rajan P
Nat Rev Urol; 2023 Aug; 20(8):502-512. PubMed ID: 36882564
[TBL] [Abstract][Full Text] [Related]
12. The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study.
Fischer S; Rothermundt C; Stalder O; Terbuch A; Hermanns T; Zihler D; Müller B; Fankhauser CD; Hirschi-Blickenstorfer A; Seifert B; Kluth LA; Ufe MP; Mingrone W; Templeton AJ; Fischer N; Rothschild S; Woelky R; Gillessen S; Cathomas R
Eur Urol Open Sci; 2023 Apr; 50():57-60. PubMed ID: 36874175
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond.
Egan J; Salari K
Urol Clin North Am; 2023 Feb; 50(1):133-143. PubMed ID: 36424077
[TBL] [Abstract][Full Text] [Related]
14. DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients.
Sequeira JP; Lobo J; Constâncio V; Brito-Rocha T; Carvalho-Maia C; Braga I; Maurício J; Henrique R; Jerónimo C
Front Oncol; 2022; 12():876732. PubMed ID: 35756620
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
